Berberine increased IKBα and decreased NF-κBp65 protein levels in diabetic mouse kidney, as well as inhibiting renal AGE generation and downregulating TGF-β1, ICAM-1, and VCAM-1 protein expression [40, 41]. This evidence concerns the gene TGFB1 and medical procedure.